How To Use Covered Calls To Generate Income
The Covered Call Defined A covered call is the sale…
Sell
32
ACTG Quote, Financials, Valuation and Earnings
Last price:
$4.36
Seasonality move
:
6.66%
Day range:
$4.29 - $4.38
52-week range:
$3.66 - $5.74
Dividend yield:
0%
P/E ratio:
8.20x
P/S ratio:
2.61x
P/B ratio:
0.78x
Volume:
90.4K
Avg. volume:
221.7K
1-year change:
15.47%
Market cap:
$421.6M
Revenue:
$125.1M
EPS (TTM):
$0.53
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Acacia Research has 61.66% upside to fair value with a price target of -- per share.
ACTG vs. S&P 500
-
Over the past 5 trading days, Acacia Research has overperformed the S&P 500 by 1.06% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Acacia Research does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Acacia Research has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Acacia Research reported revenues of $23.3M.
Earnings Growth
-
Acacia Research earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Acacia Research reported earnings per share of -$0.14.
Enterprise value:
119.1M
EV / Invested capital:
--
Price / LTM sales:
2.61x
EV / EBIT:
2.38x
EV / Revenue:
0.72x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.20x
Price / Operating cash flow:
14.53x
Enterprise value / EBITDA:
1.56x
Gross Profit (TTM):
$89.3M
Return On Assets:
8.01%
Net Income Margin (TTM):
31.44%
Return On Equity:
9.12%
Return On Invested Capital:
8.59%
Operating Margin:
-44.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $109.4M | $45.9M | $165.8M | $10.1M | $23.3M | |
| Gross Profit | $63.9M | $7.7M | $89.3M | $237K | $2.4M | |
| Operating Income | $5.8M | -$49.6M | $38.8M | -$13.2M | -$10.3M | |
| EBITDA | $143.4M | -$10M | $76.3M | $6.1M | $3.6M | |
| Diluted EPS | -$2.58 | -$0.96 | $0.53 | -$0.03 | -$0.14 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $366.1M | $669.4M | $427.2M | $484.4M | $457.6M | |
| Total Assets | $426.5M | $749.8M | $485.3M | $529.1M | $707.6M | |
| Current Liabilities | $138.3M | $204.4M | $85.4M | $21.4M | $27.9M | |
| Total Liabilities | $224.2M | $514M | $202.8M | $25.5M | $129M | |
| Total Equity | $202.3M | $235.9M | $282.5M | $503.6M | $578.6M | |
| Total Debt | $113.9M | $182.9M | $61.4M | -- | $70M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9M | -$41.7M | $65.8M | $1.2M | -$571K | |
| Cash From Investing | $161.4M | $68.8M | -$109.5M | -$601K | -$7.2M | |
| Cash From Financing | -$179.3M | $74.8M | $58.9M | -$11M | -$19.3M | |
| Free Cash Flow | -$4.6M | -$42M | -$99.6M | $1.1M | -$7.8M | |
ACTG
Sector
Market Cap
$421.6M
$661.4M
Price % of 52-Week High
75.44%
86.66%
Dividend Yield
0%
2.03%
Shareholder Yield
1.17%
3.87%
1-Year Price Total Return
15.47%
6.93%
Beta (5-Year)
0.521
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.31
200-day SMA
Sell
Level
$4.86
Bollinger Bands (100)
Sell
Level
4.41 - 4.73
Chaikin Money Flow
Buy
Level
3.6M
20-day SMA
Sell
Level
$4.37
Relative Strength Index (RSI14)
Sell
Level
45.45
ADX Line
Sell
Level
14.23
Williams %R
Neutral
Level
-54.0541
50-day SMA
Sell
Level
$4.45
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
35M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.3746)
Buy
CA Score
(Annual)
Level (1.2857)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-8.1226)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.
Stock Forecast FAQ
In the current month, ACTG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ACTG average analyst price target in the past 3 months is --.
-
Where Will Acacia Research Stock Be In 1 Year?
According to analysts, the consensus estimate is that Acacia Research share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Acacia Research?
Analysts are divided on their view about Acacia Research share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Acacia Research is a Sell and believe this share price will drop from its current level to --.
-
What Is Acacia Research's Price Target?
The price target for Acacia Research over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ACTG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Acacia Research is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ACTG?
You can purchase shares of Acacia Research via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Acacia Research shares.
-
What Is The Acacia Research Share Price Today?
Acacia Research was last trading at $4.36 per share. This represents the most recent stock quote for Acacia Research. Yesterday, Acacia Research closed at $4.33 per share.
-
How To Buy Acacia Research Stock Online?
In order to purchase Acacia Research stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target a Dividend King?
Popular retail giant Target Corporation (NYSE:TGT) has been in a…
Is COWZ ETF a Good Investment?
There’s a reason even Warren Buffett advocates his heirs to…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 110x
Sell
40
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
HEES alert for Jan 15
H&E Equipment Services [HEES] is down 1.38% over the past day.
Sell
26
SIG alert for Jan 15
Signet Jewelers [SIG] is up 1.57% over the past day.
Sell
45
WGS alert for Jan 15
GeneDx Holdings [WGS] is up 0.81% over the past day.
